Asian Spectator

Men's Weekly

.

PYC'S FOURTH DRUG CANDIDATE HAS DISEASE-MODIFYING POTENTIAL IN POLYCYSTIC KIDNEY DISEASE

  • Written by PR Newswire Asia - Asian Spectator
  • PYC has developed a new drug candidate for the >5 million people worldwide[1] with Polycystic Kidney Disease (PKD)
  • This drug candidate has demonstrated efficacy in human models derived from the kidneys of patients with end-stage renal failure due to PKD[2]
  • PKD is a life-changing disease affecting 1 in every 1,000 people[3]
  • Half of the patient...

More Articles ...

  1. Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)

Magazine

Bali kian disesaki turis: Wisata desa jadi alternatif menjanjikan

● Banyak desa wisata potensial tapi kurang dilirik wisatawan.● Padahal desa wisata bisa jadi alternatif bahkan subtitusi titik pariwisata nasional.● Selain promosi dan akses, pengemb...

Lumpur sisa banjir tidak boleh dibuang sembarangan, bisa dimanfaatkan atau dijual

● Lumpur sisa banjir yang dibuang kembali ke sungai, bisa memperbesar risiko banjir di masa depan. ● Perlu penanganan khusus agar lumpur tidak membahayakan lingkungan dan kesehatan.●...

Ketika publik tak lagi percaya ahli, bagaimana memulihkan Indonesia dari krisis kepakaran?

● Cina mewajibkan kualifikasi akademis bagi ‘content creator’ untuk menegaskan nilai kepakaran.● Di Indonesia, krisis kepakaran dipicu lemahnya ekosistem pengetahuan, budaya ri...